Serum Life Sciences Ltd. (SLS) is a wholly owned subsidiary of Serum Institute of India Pvt. Ltd (SIIPL), the world's largest vaccine manufacturer by number of doses produced and sold globally. As part of the Cyrus Poonawalla Group, SLS is committed to advancing global public health by protecting lives from birth onwards through improved access to high-quality vaccines and diagnostics.
18 November, 2025 - Press Release
Serum Institute of India Pvt. Ltd. in collaboration with its UK subsidiary Serum Life Sciences Ltd , is pleased to announce that the MHRA, United Kingdom, has granted Marketing Authorisation for SIILTIBCY®....Read more
27 June, 2025 - University of Oxford
The University of Oxford held a groundbreaking ceremony on Tuesday 24 June to celebrate the start of construction of the Cyrus Poonawalla Vaccines Research Building...Read more
11 June, 2025 - Press Release
SIIPL has become the first vaccine manufacturer to submit a Prequalification Dossier (PQD) for a vaccine...Read more
18 February, 2025 - Press Release
SIILTIBCY®, a novel tuberculosis (TB) diagnostic test, has received full marketing authorisation from the European Commission (EC)...Read more
03 February, 2025 - Press Release
Bilthoven Biologicals (BBio- a Cyrus Poonawalla Group company), has officially inaugurated its pandemic preparedness vaccine facilities...Read more
31 October, 2024 - TIME
TIME "The Best Inventions of 2024" lists University of Oxford and the Serum Institute of India R21/Matrix-M™ Malaria Vaccine as "A Game-Changing Vaccine"...Read more
30 October, 2024 - Press Release
Serum Institute of India Pvt. Ltd. receives positive CHMP opinion from European Medicines Agency (EMA) for SIILTIBCY® ...Read more
20 May, 2024 - Press Release
SII marks a significant milestone with the shipment of its first set of R21/Matrix-M™ malaria vaccine to Africa.....Read more
03 May, 2024 - Press Release
The collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®....Read more
25 April, 2024
On World Malaria Day, the architects behind the R21/Matrix-M vaccine present their take on the road ahead....Read more
16 April, 2024 - Press Release
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease...Read more
12 April, 2024 - Press Release
In a landmark collaboration announced today, Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells...Read more
02 October, 2023 - Press Release
The R21/Matrix-M™ malaria vaccine developed by the University of Oxford and the Serum Institute of India...Read more
06 July, 2023
Hon'ble UK Minister of State; Science, Technology & Innovation, George Freeman and UK Trade Commissioner for South Asia, Harjinder Kang along with members of the UK Trade Commission visit Serum Institute Of India...Read more
17 December, 2021 - Press Release
WHO has granted Emergency Use Listing (EUL) for NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine 'COVOVAX™'... Read more
15 December, 2021
The Poonawalla Vaccines Research Building is to be established at Oxford University following £50m funding commitment from Serum Life Sciences Ltd... Read more
22 September, 2021
Serum Life Sciences Ltd announces a strategic partnership with Oxford Biomedica, with the objective of building long term capacity in the UK... Read more
16 March, 2021 - BBC HARDtalk
Adar Poonawalla went all-in on a coronavirus vaccine production deal with Astrazeneca, can he make enough to supply the world?... Read more
03 March 2021 - The Economist
By the end of the year, Mr Poonawalla says, it will add 1.5bn covid-19 shots,... Read more
28 February, 2021 - BBC News
As pharmaceutical giants ramp up production in the race to vaccinate the world, one firm has shot into the lead... Read more
14 February 2021 - The Guardian
Adar Poonawalla, chief executive of the Serum Institute of India, on vaccines, regulation and what comes next... Read more
12 January, 2021
'An emotional moment for the team at @SerumInstIndia,...Read more
23 December, 2020
Serum Institute of India (SIIPL) has partnered with...Read more
11 November 2020 - Washington Post
Adar Poonawalla is an Indian billionaire whose family-owned firm makes more vaccines... Read more
22 September, 2020
Adar Poonawalla explains the timing, challenges...View Part 1
22 September, 2020
Adar Poonawalla explains the timing, challenges...View Part 2
16 September, 2020
Novavax, Inc. announced an amendment to its existing agreement... Read more
11 August, 2020
The Serum Institute of India is preparing to crank out a billion doses. And that's just the beginning... Read more
7 August, 2020
The Bill & Melinda Gates Foundation said it is backing the world’s largest vaccine maker... Read more
7 August, 2020
Geneva, 7 August 2020 – A new landmark... Read more
6 August, 2020
Novavax, Inc. announced a license agreement with Serum Institute of India for the development... Read more
01 August 2020 - The New York Times
The world’s largest vaccine producer, the Serum Institute,... Read more
16 July 2020 - Politico
Adar Poonawalla is seizing on the COVID-19 fight to try to break down the policies protecting Big Pharma...Read more
04 June, 2020
Poonawalla is betting big on a Covid-19 vaccine, and preparing for the next possible pandemic...Read more
